FDA has approved Relistor for opioid-induced constipation – Xagena Medical News

The FDA ( Food and Drug Administration ) has approved Relistor ( Methylnaltrexone bromide) to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a continuous basis to help alleviate their pain.

Leave a Reply

Your email address will not be published. Required fields are marked *